Effects of horizontal versus vertical switching of disease-modifying treatment after platform drugs on disease activity in patients with relapsing–remitting multiple sclerosis in Austria

OBJECTIVES: To compare in a nationwide observational cohort the effectiveness, frequency and reasons for treatment interruption of dimethylfumarate (DMF) and teriflunomide (TERI) (horizontal switchers) versus alemtuzumab (AZM), cladribine (CLAD), fingolimod (FTY), natalizumab (NTZ), ocrelizumab (OCR...

Descripción completa

Detalles Bibliográficos
Autores principales: Guger, Michael, Enzinger, Christian, Leutmezer, Fritz, Di Pauli, Franziska, Kraus, Jörg, Kalcher, Stefan, Kvas, Erich, Berger, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Original Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188397/
https://www.ncbi.nlm.nih.gov/pubmed/36862148
http://dx.doi.org/10.1007/s00415-023-11644-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188397/
https://www.ncbi.nlm.nih.gov/pubmed/36862148
http://dx.doi.org/10.1007/s00415-023-11644-y

Ejemplares similares